NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading ->
For the first time, more than half of people in the world living with HIV have access to treatment, UNAIDS said in a report released today in Geneva. In addition, AIDS-related deaths have been nearly cut in half since 2005, it said. As of 2016, nearly 20 million people were living with HIV. Continue reading ->
The global network of national influenza centres is at the core of the World Health Organization system of influenza surveillance and response. All year round those national influenza centres collect, interpret and share flu samples or genetic information with the WHO so that seasonal vaccines can be manufactured, and potential pandemics adequately identified and contained. Continue reading ->
A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors. Continue reading ->
The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading ->
Access to affordable and quality medicines for all is one of the major commitments of the World Health Organization, and its new medicines and health products strategic framework for the next 15 years calls for new research and development (R&D) models, including delinkage of the R&D costs from the price of products, and fair pricing. Continue reading ->
Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea. Continue reading ->
On the eve of the G20 meeting in Hamburg, Germany, German politicians described positions on free trade and climate as the most difficult issues. Expectations from civil society groups in the G20 results are modest at best and the 6 July protest march “Welcome to Hell” was cancelled after clashes between the police and parts of the protestors. Continue reading ->
Tedros Adhanom Ghebreyesus began his first week as director-general of the UN World Health Organization by addressing the WHO staff with his vision for the organisation and the world. Top of the list? Humanity. Continue reading ->
An African medicines agency, the continent’s first super-regulator, could be approved as soon as next year. Continue reading ->